adenosine A2b antagonists (Hoffman-La Roche)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameadenosine A2b antagonists (Hoffman-La Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Lung DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Lung DiseasesAsthma

Other Information

ATC CodeN/A
Related LinksN/A